Financial Summary (All financials)
| In millions, except per share items | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 |
| Revenues | 0.0 | 0.0 | 0.0 | 26.1 |
| Revenue growth | | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 26.1 |
| Gross margin | | | | 100.0% |
| Selling, general and administrative | | | | 27.1 |
| Research and development | 92.4 | 92.2 | 32.4 | |
| General and administrative | 46.3 | 18.6 | 4.6 | |
| EBIT | -147.4 | -110.8 | -37.0 | -0.9 |
| EBIT margin | | | | -3.5% |
| Pre-tax income | -146.7 | -111.3 | -37.0 | -27.0 |
| Income taxes | 0.1 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | 0.0% |
| Net income | -146.7 | -111.3 | -37.1 | -27.0 |
| Net margin | | | | -103.2% |
| |
| Diluted EPS | ($4.82) | ($4.43) | ($2.16) | ($10.10) |
| Shares outstanding (diluted) | 30.4 | 25.1 | 17.1 | 2.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|